|
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 34782936 | MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. | Virchows Arch | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 33770057 | Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma. | Int J Gynecol Pathol | 2022 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 32976626 | Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses. | Int J Cancer | 2021 |
| 33981016 | Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents. | Br J Cancer | 2021 |
| 32473302 | Prognostic gene expression signature for high-grade serous ovarian cancer. | Ann Oncol | 2020 |
| 32083017 | Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma. | Front Oncol | 2020 |
| 32555365 | Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. | Br J Cancer | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 29336210 | Semi-supervised identification of cancer subgroups using survival outcomes and overlapping grouping information. | Stat Methods Med Res | 2019 |
| 31239549 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. | Mod Pathol | 2019 |
| 31548585 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers. | Nat Commun | 2019 |
| 30979743 | Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma. | Clin Cancer Res | 2019 |
| 31001917 | Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. | Cancer Med | 2019 |
| 30683880 | Shared heritability and functional enrichment across six solid cancers. | Nat Commun | 2019 |
| 30481095 | Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women. | J Womens Health (Larchmt) | 2019 |
| 30480647 | Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem. | Int J Gynecol Pathol | 2019 |
| 30528360 | Racial disparities in treatment and survival from ovarian cancer. | Cancer Epidemiol | 2019 |
| 30326146 | Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome. | Histopathology | 2019 |
| 29247577 | Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium. | Cancer Sci | 2018 |
| 30134598 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. | Int J Mol Sci | 2018 |
| 30054336 | A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. | Cancer Res | 2018 |
| 30121132 | Histotype classification of ovarian carcinoma: A comparison of approaches. | Gynecol Oncol | 2018 |
| 30062862 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2018 |
| 29979793 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. | PLoS One | 2018 |
| 29555990 | Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. | Br J Cancer | 2018 |
| 29502561 | MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. | Mayo Clin Proc | 2018 |
| 29309296 | High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases. | Am J Surg Pathol | 2018 |
| 28050675 | Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium. | Cancer Causes Control | 2017 |
| 28194593 | Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles. | Cancer Causes Control | 2017 |
| 28103614 | Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. | Br J Cancer | 2017 |
| 28293802 | History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. | Cancer Causes Control | 2017 |
| 28346442 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. | Nat Genet | 2017 |
| 28264438 | Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications. | Int J Mol Sci | 2017 |
| 28466107 | Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES). | Cancer Causes Control | 2017 |
| 28115406 | Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. | Cancer Epidemiol Biomarkers Prev | 2017 |
| 29049607 | Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. | JAMA Oncol | 2017 |
| 29117355 | Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. | J Natl Cancer Inst | 2017 |
| 28535290 | Dietary Quality and Ovarian Cancer Risk in African-American Women. | Am J Epidemiol | 2017 |
| 28864456 | History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. | Cancer Epidemiol Biomarkers Prev | 2017 |
| 27697780 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers. | Cancer Epidemiol Biomarkers Prev | 2017 |
| 25940428 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. | Gynecol Oncol | 2016 |
| 26549109 | Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer. | Gynecol Oncol | 2016 |
| 27595995 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. | J Med Genet | 2016 |
| 27911851 | Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. | Oncotarget | 2016 |
| 27533245 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. | Oncotarget | 2016 |
| 27299959 | Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. | Br J Cancer | 2016 |
| 27197285 | Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. | Cancer Epidemiol Biomarkers Prev | 2016 |